drugset / Trial / NCT00849485
Levetiracetam 750 mg Tablets Under Non-Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The objective of this study is to compare the rate and extent of absorption of a test formulation of Levetiracetam tablets versus the reference Keppra® administered as a 1 x 750 mg tablet under fed conditions.
Timeline
- Start
- 2005-11
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 750 mg | — |
Indications
No indication recorded.